Excess Mortality Associated With Hypopituitarism in Adults: A Meta-Analysis of Observational Studies
The DOI matches its Crossref record; 33 of the 34 references it cites were found in a registry or an index.
Abstract
Context: Several previous observational studies showed an association between hypopituitarism and excess mortality. Reports on reduction of standard mortality ratio (SMR) with GH replacement have been published recently. Objective: This meta-analysis assessed studies reporting SMR to clarify mortality risk in hypopituitary adults and also the potential benefit conferred by GH replacement. Data Sources: A literature search was performed in Medline, Embase, and Cochrane library up to March 31, 2014. Eligibility Criteria: Studies with or without GH replacement reporting SMR with 95% confidence intervals (95% CI) were included. Data Extraction and Analysis: Patient characteristics, SMR data, and treatment outcomes were independently assessed by two authors, and with consensus from third author, studies were selected for analysis. Meta-analysis was performed in all studies together, and those without and with GH replacement separately, using the statistical package metafor in R. Results: Six studies reporting a total of 19 153 hypopituiatary adults with a follow-up duration of more than 99 000 person years were analyzed. Hypopituitarism was associated with an overall excess mortality (weighted SMR, 1.99; 95% CI, 1.21–2.76) in adults. Female hypopituitary adults showed higher SMR compared with males (2.53 vs 1.71). Onset of hypopituitarism at a younger age was associated with higher SMR. GH replacement improved the mortality risk in hypopituitary adults that is comparable to the background population (SMR with GH replacement, 1.15; 95% CI, 1.05–1.24 vs SMR without GH, 2.40; 95% CI, 1.46–3.34). GH replacement conferred lower mortality benefit in hypopituitary women compared with men (SMR, 1.57; 95% CI, 1.38–1.77 vs 0.95; 95% CI, 0.85–1.06). Limitations: There was a potential selection bias of benefit of GH replacement from a post-marketing data necessitating further evidence from long-term randomized controlled trials. Conclusions: Hypopituitarism may increase premature mortality in adults. Mortality benefit from GH replacement in hypopituitarism is less pronounced in women than men.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Left untreated, anterior pituitary deficiencies are associated with decreased health and quality of life [55-59].”
From Neuroendocrine Disruptions Following Head Injury (2023) · cites this paper as [59]
In the citing paper
“undiagnosed and untreated deficiencies confer increased morbidity and mortality, which can be reversed by appropriate hormone replacement.”
From Neuroendocrine Disruptions Following Head Injury (2023) · cites this paper as [59]
In the citing paper
“However, GH replacement may reduce excess mortality from an SMR of 2.40 (95% CI 1.46-3.34) to 1.99 (95% CI 1.21-2.76),especially in men (60).”
From Hormonal Replacement in Hypopituitarism in Adults: An Endocrine Society Clinical Practice Guideline (2016) · cites this paper as [60]
Citations
Cites
Preferred Reporting Items for Systematic Reviews and Meta-Analyses: the PRISMA statement
Moher, D., Liberati, A., Tetzlaff, J., Altman, D. G., & for the PRISMA Group (2009) · BMJ · doi:10.1136/bmj.b2535 · Cited by 83,823
Preferred reporting items for systematic reviews and meta-analyses: the PRISMA Statement.
(2009) · PubMed Central · Cited by 44,859
Conducting Meta-Analyses in R with the metafor Package
Viechtbauer, W. (2010) · Journal of Statistical Software · doi:10.18637/jss.v036.i03 · Cited by 20,464 · cited 1×
“Quality assessment of the included articles was performed using the Newcastle Ottawa Scale (NOS) for cohort studies (17), modified for this meta-analysis.”
Method(2014) · Medical Entomology and Zoology · Cited by 17,633
Premature mortality due to cardiovascular disease in hypopituitarism
Rosén, T., & Bengtsson, B.-Å. (1990) · The Lancet · doi:10.1016/0140-6736(90)91812-o · Cited by 1,402 · cited 1×
“The increased risk of premature mortality associated with hypopituitarism was first identified by Rosén and Bengtsson (5) more than two decades ago.”
BackgroundThe prevalence of pituitary adenomas: A systematic review
Ezzat, S., Asa, S. L., Couldwell, W. T., Barr, C. E., Dodge, W. E., Vance, M. L., & McCutcheon, I. E. (2004) · Cancer · doi:10.1002/cncr.20412 · Cited by 1,345
Salomon, F., Cuneo, R. C., Hesp, R., & Sönksen, P. H. (1989) · New England Journal of Medicine · doi:10.1056/nejm198912283212605 · Cited by 1,326 · cited 1×
“3 Median: 53 M; 51F N/A 56 (31) 119 (69) Bülow et al, 1997 (7) 344 62.”
Association between premature mortality and hypopituitarism
Tomlinson, J., Holden, N., Hills, R., Wheatley, K., Clayton, R., Bates, A., Sheppard, M., & Stewart, P. (2001) · The Lancet · doi:10.1016/s0140-6736(00)04006-x · Cited by 1,006
Self-citationBENEFICIAL EFFECTS OF GROWTH HORMONE TREATMENT IN GH-DEFICIENT ADULTS
Jørgensen, J. O. L., Thuesen, L., Ingemann-Hansen, T., Pedersen, S. A., Jørgensen, I., Skakkebaek, N. E., & Christiansen, J. S. (1989) · The Lancet · doi:10.1016/s0140-6736(89)92328-3 · Cited by 890
Increased cerebrovascular mortality in patients with hypopituitarism
Bülow, B., Hagmar, L., Mikoczy, Z., Nordström, C., & Erfurth, E. M. (1997) · Clinical Endocrinology · doi:10.1046/j.1365-2265.1997.d01-1749.x · Cited by 542
The effect of hypopituitarism on life expectancy.
Bates, A. S., Van't Hoff, W., Jones, P. J., & Clayton, R. N. (1996) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.81.3.8772595 · Cited by 475 · cited 4×
“The lower SMR from cancer reported in the more recent studies (14, 15) compared with the older ones (6, 7) may be related to the relatively younger age of subjects in the recent studies.”
BackgroundResultInfluentialSelf-citationMortality in Patients with Pituitary Disease
Sherlock, M., Ayuk, J., Tomlinson, J. W., Toogood, A. A., Aragon-Alonso, A., Sheppard, M. C., Bates, A. S., & Stewart, P. M. (2010) · Endocrine Reviews · doi:10.1210/er.2009-0033 · Cited by 392 · cited 3×
“7%, these were most often microadenomas with little clinical significance (1, 4).”
BackgroundGurney, J. G., Kadan‐Lottick, N. S., Packer, R. J., Neglia, J. P., Sklar, C. A., Punyko, J. A., Stovall, M., Yasui, Y., Nicholson, H. S., Wolden, S., et al. (2003) · Cancer · doi:10.1002/cncr.11095 · Cited by 369
Prevalence and incidence of hypopituitarism in an adult Caucasian population in northwestern Spain
Regal, M., Páramo, C., Sierra, J. M., & García‐Mayor, R. V. (2001) · Clinical Endocrinology · doi:10.1046/j.1365-2265.2001.01406.x · Cited by 354
Svensson, J., Bengtsson, B.-Å., Rosén, T., Odén, A., & Johannsson, G. (2004) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2003-031601 · Cited by 237 · cited 5×
“Although Svensson et al (10) observed an improvement of the incidence of fatal myocardial infarctions in 2004, the study by van Bunderen et al (14) showed convincing reduction in overall mortality in GHtreated hypopituitary adults.”
BackgroundResultInfluentialMueller, S., Fullerton, H. J., Stratton, K., Leisenring, W., Weathers, R. E., Stovall, M., Armstrong, G. T., Goldsby, R. E., Packer, R. J., Sklar, C. A., et al. (2013) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2013.03.034 · Cited by 153 · cited 1×
“Increased risk of atherosclerosis and strokes had been demonstrated in patients who had cranial irradiation for other reasons (25, 26).”
BackgroundPituitary Adenomas in Sweden between 1958 and 1991: Incidence, Survival, and Mortality1
Nilsson, B., Gustavsson-Kadaka, E., Bengtsson, B.-Å., & Jonsson, B. (2000) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.85.4.6498 · Cited by 151 · cited 2×
“Significant increase in malignancy-related deaths were also observed in younger patients with hypopituitarism (6, 8, 10).”
Backgroundvan Bunderen, C. C., van Nieuwpoort, I. C., Arwert, L. I., Heymans, M. W., Franken, A. A. M., Koppeschaar, H. P. F., van der Lely, A. J., & Drent, M. L. (2011) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2011-1215 · Cited by 133 · cited 10×
“The age-specific SMR (95% CI) reported by van Bunderen et al (14) for age-groups 30 years, 30–45 years, 45–60 years, and 60 years were: 8.”
BackgroundResultInfluentialOverall and cause-specific mortality in GH-deficient adults on GH replacement
Gaillard, R. C., Mattsson, A. F., Åkerblad, A.-C., Bengtsson, B.-Å., Cara, J., Feldt-Rasmussen, U., Kołtowska-Häggström, M., Monson, J. P., Saller, B., Wilton, P., et al. (2012) · European Journal of Endocrinology · doi:10.1530/eje-11-1028 · Cited by 130 · cited 10×
“Although Bülow et al (7) and Tomlinson et al (9) reported higher SMR related to respiratory diseases in their cohorts, Gaillard et al (15) reported lower SMR compared with the background popFigure 4.”
BackgroundMethodResultInfluentialMortality and GH deficiency: a nationwide study
Stochholm, K., Gravholt, C. H., Laursen, T., Laurberg, P., Andersen, M., Kristensen, L. Ø., Feldt-Rasmussen, U., Christiansen, J. S., Frydenberg, M., & Green, A. (2007) · European Journal of Endocrinology · doi:10.1530/eje-07-0013 · Cited by 129 · cited 1×
“The higher SMR reported in younger patients compared with the background population may reflect an increased risk of vascular disease and malignant disease, and the related mortality associated with hypopituitarism and its treatment (20).”
BackgroundHypopituitarism: Clinical Features, Diagnosis, and Management
Toogood, A. A., & Stewart, P. M. (2008) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/j.ecl.2007.10.004 · Cited by 120 · cited 1×
“The pituitary gland regulates the functions of human endocrine system by its control over the other hormone-producing organs, and the biochemical deficiency of one or more of the pituitary hormones is termed hypopituitarism (1, 2).”
BackgroundPituitary Adenomas in Sweden between 1958 and 1991: Incidence, Survival, and Mortality
Nilsson, B. (2000) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.85.4.1420 · Cited by 107
Nielsen, E. H., Lindholm, J., Laurberg, P. T., Bjerre, P., Christiansen, J. S., Hagen, C., Juul, S., Jørgensen, J., Kruse, A., & Stochholm, K. (2007) · Pituitary · doi:10.1007/s11102-007-0018-x · Cited by 87
Initial Gamma Knife radiosurgery for nonfunctioning pituitary adenomas
Lee, C., Kano, H., Yang, H., Xu, Z., Yen, C.-P., Chung, W., Pan, D. H.-C., Lunsford, L. D., & Sheehan, J. P. (2014) · Journal of neurosurgery · doi:10.3171/2013.11.jns131757 · Cited by 73 · cited 1×
“Newonset or worsening hypopituitarism was reported in 24% of NFA managed by gamma knife radiosurgery in a recent study (22).”
BackgroundVerhelst, J., Mattsson, A. F., Luger, A., Thunander, M., Góth, M. I., Kołtowska-Häggström, M., & Abs, R. (2011) · European Journal of Endocrinology · doi:10.1530/eje-11-0599 · Cited by 71 · cited 1×
“Significantly higher proportion of patients with hypopituitarism also had metabolic syndrome compared with the normal population, making them more prone to develop premature atherosclerosis (23, 24).”
BackgroundRobenshtok, E., Benbassat, C. A., Hirsch, D., Tzvetov, G., Cohen, Z. R., Masri‐Iraqi, H., Gorshtein, A., Toledano, Y., & Shimon, I. (2013) · Endocrine Practice · doi:10.4158/ep13182.or · Cited by 59 · cited 1×
“Similarly, as the age of the population is increasing worldwide, the incidence of hypopituitarism is also expected to increase in the future, because older people with NFA tend to have lower recovery rates even after successful treatment of the tumors (19).”
BackgroundExcess mortality in women with pituitary disease: a meta‐analysis
Nielsen, E. H., Lindholm, J., & Laurberg, P. (2007) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2007.02947.x · Cited by 58 · cited 3×
“There were also differences in the sex-specific mortality rates between men and women (12, 13).”
BackgroundResultInfluentialRagnarsson, O., Mattsson, A. F., Monson, J. P., Filipsson Nyström, H., Åkerblad, A.-C., Kołtowska-Häggström, M., & Johannsson, G. (2014) · European Journal of Endocrinology · doi:10.1530/eje-14-0397 · Cited by 46 · cited 1×
“Lower dose of hydrocortisone replacement has shown to improve the quality of life in hypopituitary adults in a recent study (29).”
BackgroundRadiotherapy for pituitary adenomas: long-term outcome and complications
Rim, C. H., Yang, D. S., Park, Y. J., Yoon, W. S., Lee, J. A., & Kim, C. Y. (2011) · Radiation Oncology Journal · doi:10.3857/roj.2011.29.3.156 · Cited by 41 · cited 1×
“Patients treated with irradiation for pituitary adenomas had strokes near radiation field (27).”
BackgroundPremature carotid artery disease in pediatric cancer survivors treated with neck irradiation
Meeske, K., Siegel, S. E., Gilsanz, V., Bernstein, L., Nelson, M. B., Sposto, R., Weaver, F. A., Lavey, R. S., Mack, M. P. H. W. J., & Nelson, M. D. (2009) · Pediatric Blood & Cancer · doi:10.1002/pbc.22111 · Cited by 40 · cited 1×
“Increased risk of atherosclerosis and strokes had been demonstrated in patients who had cranial irradiation for other reasons (25, 26).”
BackgroundUpdate in Mortality in GH-Treated Patients
Erfurth, E. M. (2013) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2013-2415 · Cited by 29 · cited 1×
“The improvement of CV mortality in the recent study cohorts with hypopituitarism may also be related to better utilization of new cardiovascular drugs and therapeutic interventions (28).”
BackgroundIs Vascular Mortality Increased in Hypopituitarism?
Erfurth, E. M., BüAlow, B., & Hagmar, L. (2000) · Pituitary · doi:10.1023/a:1009901707125 · Cited by 28
Carotid atheromatic plaque is commonly associated with hypopituitary men
Kim, J. Y., Hong, J. W., Rhee, S. Y., Kim, C. S., Kim, D. J., & Lee, E. J. (2010) · Pituitary · doi:10.1007/s11102-010-0265-0 · Cited by 5 · cited 1×
“Significantly higher proportion of patients with hypopituitarism also had metabolic syndrome compared with the normal population, making them more prone to develop premature atherosclerosis (23, 24).”
Background
Cited by
Hormonal Replacement in Hypopituitarism in Adults: An Endocrine Society Clinical Practice Guideline
Fleseriu, M., Hashim, I. A., Karavitaki, N., Melmed, S., Murad, M. H., Salvatori, R., & Samuels, M. H. (2016) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2016-2118 · Cited by 945
Systemic Complications of Acromegaly and the Impact of the Current Treatment Landscape: An Update
Gadelha, M. R., Kasuki, L., Lim, D. S. T., & Fleseriu, M. (2019) · Endocrine Reviews · doi:10.1210/er.2018-00115 · Cited by 363
Growth hormone — past, present and future
Ranke, M. B., & Wit, J. M. (2018) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2018.22 · Cited by 346
Diagnosis and Management of Pituitary Adenomas: A Review
Tritos, N. A., & Miller, K. K. (2023) · JAMA · doi:10.1001/jama.2023.5444 · Cited by 331
Yuen, K. C. J., Biller, B. M. K., Radovick, S., Carmichael, J. D., Jasim, S., Pantalone, K. M., & Hoffman, A. R. (2019) · Endocrine Practice · doi:10.4158/gl-2019-0405 · Cited by 298
Metadata
- Authors
- Pappachan, J. M., Raskauskiene, D., Kutty, V. R., & Clayton, R. N.
- Affiliations
- Walsall Manor Hospital (GB)
- Sree Chitra Thirunal Institute for Medical Sciences and Technology (IN)
- University Hospitals of North Midlands NHS Trust (GB)
- Corresponding author
- Pappachan, Joseph M.
- Venue
- The Journal of Clinical Endocrinology & Metabolism
- Publisher
- The Endocrine Society
- Published
- 2015-04-01
- Volume
- 100
- Issue
- 4
- Pages
- 1405-1411
- ISSN
- 0021-972X (ISSN-L)
- 1945-7197
- OpenAlex
- W2097556482
- Semantic Scholar
- 00593eb004f6fde4fa72eed78a1247a323891575
- Cited by
- 138
- References
- 34
- Citations by year
- 2026: 6 · 2025: 18 · 2024: 18 · 2023: 19 · 2022: 16 · 2021: 9 · 2020: 13 · 2019: 9 · 2018: 10 · 2017: 10 · 2016: 8 · 2015: 1
- FWCI
- 1.46
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- The Journal of Clinical Endocrinology & Metabolism (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Growth Hormone and Insulin-like Growth Factors
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Pituitary Gland Disorders and Treatments
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Hormonal and reproductive studies
- Keywords
- excess mortality, standardized mortality ratio, growth hormone replacement therapy, premature mortality, sex differences, post-marketing surveillance
- MeSH terms
- Adult, Female, Humans, Hypopituitarism, Male, Middle Aged, Human Growth Hormone, Hormone Replacement Therapy, Observational Studies as Topic
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.